|
ASXL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.5499000000373E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.157220E-04 |
| Normal-vs-Stage2 |
1.558570E-03 |
| Normal-vs-Stage3 |
8.93790000011663E-07 |
| Normal-vs-Stage4 |
2.23859999999299E-05 |
| Stage1-vs-Stage2 |
8.149400E-01 |
| Stage1-vs-Stage3 |
1.642760E-01 |
| Stage1-vs-Stage4 |
2.794000E-01 |
| Stage2-vs-Stage3 |
4.934200E-01 |
| Stage2-vs-Stage4 |
4.976400E-01 |
| Stage3-vs-Stage4 |
9.076000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50396999999414E-05 |
| Normal-vs-AfricanAmerican |
4.694000E-02 |
| Normal-vs-Asian |
2.155600E-04 |
| Caucasian-vs-AfricanAmerican |
3.502000E-01 |
| Caucasian-vs-Asian |
6.041200E-01 |
| AfricanAmerican-vs-Asian |
2.525200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.61149999905663E-08 |
| Normal-vs-Female |
7.89770000000356E-05 |
| Male-vs-Female |
1.977710E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.282820E-03 |
| Normal-vs-Age(41-60Yrs) |
5.19169999990687E-07 |
| Normal-vs-Age(61-80Yrs) |
1.92681999999778E-05 |
| Normal-vs-Age(81-100Yrs) |
6.203300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.848200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.171200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.844600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.163000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.334200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.799800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.943800E-01 |
| Classical-VS-Follicular |
2.236400E-02 |
| Classical-VS-Other |
6.313600E-02 |
| Classical-VS-Normal |
2.762400E-04 |
| Tall-VS-Follicular |
6.791600E-01 |
| Tall-VS-Other |
1.388160E-01 |
| Tall-VS-Normal |
4.618800E-04 |
| Follicular-VS-Other |
2.478600E-01 |
| Follicular-VS-Normal |
8.51240000043774E-07 |
| Other-VS-Normal |
9.827900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30089999994532E-06 |
| Normal-vs-N1 |
1.583520E-04 |
| N0-vs-N1 |
7.740800E-01 |
|
|
